Wuxi Translational Medicine Research Center

WuXi AppTec Translational Medicine is a specialized contract research organization (CRO) division that provides integrated solutions to bridge the gap between preclinical discovery and clinical development. Based in Wuxi, China, the center offers a comprehensive suite of services including biomarker discovery, validation, and testing, as well as genomic analysis and clinical trial bioanalysis. By leveraging advanced technologies such as next-generation sequencing (NGS), flow cytometry, and mass spectrometry, the center supports global biopharmaceutical partners in patient stratification and companion diagnostic development. The facility is CAP-accredited and CLIA-certified, ensuring that its data meets the rigorous standards required for global regulatory submissions. Its mission is to accelerate the development of precision medicines through high-quality, data-driven translational research.